Copertina

Targeted metabolomics reveals novel biomarkers for gestational diabetes mellitus

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Zhuangfei Xu, Jiali Fang, Yi Wang, Xiaoting Wu, Lan Liu, Xianwei Cui, Hong Zhong, Tianying Zhong
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Diabetes, Obesity and Metabolism
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Metabolomic network reveals novel biomarkers for type 2 diabetes mellitus in the UK Biobank study
di: Jiahao Liu, et al.
Pubblicazione: (2025)

A meta‐analysis of adverse offspring health outcomes in patients with gestational diabetes mellitus
di: Jiewen Guan, et al.
Pubblicazione: (2025)

Taste perception genomics in gestational diabetes mellitus: A systematic review
di: Vishnu Shivam, et al.
Pubblicazione: (2024)

Unveiling urinary diagnostic biomarkers for diabetic kidney disease using metabolomics and machine learning approaches
di: Yuan Sun, et al.
Pubblicazione: (2025)

Increased gallbladder emptying and reduced GLP ‐1 response in pregnancy with and without gestational diabetes mellitus
di: Ida M. Gether, et al.
Pubblicazione: (2024)

Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes
di: Resham Lal Gurung, et al.
Pubblicazione: (2025)

Body mass index trajectories and time in target range after delivery and long‐term type 2 diabetes risk in women with a history of gestational diabetes mellitus
di: Lixia Zhang, et al.
Pubblicazione: (2024)

Prevalence and concordance of cardiometabolic risk markers and health behaviour among couples after a gestational diabetes mellitus‐affected pregnancy
di: Majken Lillholm Pico, et al.
Pubblicazione: (2025)

The cardio‐metabolic protein profile is associated with development of type 2 diabetes at long term follow‐up after gestational diabetes mellitus: Results from the OGFUS study
di: Simone J. Hallig, et al.
Pubblicazione: (2025)

Five years liraglutide treatment improves glucose tolerance in women with previous gestational diabetes mellitus—Results from a randomised controlled trial
di: Emilie S. Andersen, et al.
Pubblicazione: (2025)

Identification of diagnostic biomarkers used in the diagnosis of cardiovascular diseases and diabetes mellitus: A systematic review of quantitative studies
di: Megan Wilson, et al.
Pubblicazione: (2024)

Oxidative stress, senescence and mRNA decay in peripheral blood mononuclear cells of women with gestational diabetes mellitus ‐link to increased cardiovascular disease risk
di: Tove Lekva, et al.
Pubblicazione: (2025)

Evaluating global epidemiology of type 2 diabetes mellitus among the working‐age population: A 60‐year study by interpretable machine learning framework
di: Xuan Zhong, et al.
Pubblicazione: (2025)

Income‐related inequities in the progression from gestational to type 2 diabetes: Findings from Taiwan's maternal and child health database
di: Fu‐Shun Yen, et al.
Pubblicazione: (2025)

Integrated biomarker profiling for predicting the response of type 2 diabetes to metformin
di: Jianglan Long, et al.
Pubblicazione: (2024)

Plasma proteomics identifies potential drug targets for diabetic polyneuropathy: Evidence from prospective cohorts and genetic analysis
di: Haoning Lan, et al.
Pubblicazione: (2025)

Comparative prognostic value of nine cardiorenal biomarkers for mortality among adults with prediabetes and diabetes
di: Chunyan Chai, et al.
Pubblicazione: (2026)

Safety, pharmacokinetics and pharmacodynamics of multiple‐dose noiiglutide ( SHR20004 ), a novel GLP ‐1 receptor agonist, in Chinese obese subjects without diabetes mellitus
di: Yang Zou, et al.
Pubblicazione: (2024)

Comprehensive risk factor control and its biomarker‐mediated association with diabetic microvascular complications
di: Jing‐Wei Gao, et al.
Pubblicazione: (2025)

Gut microbiota‐mediated branched‐chain amino acid metabolism: A novel mechanism by which Bacteroides uniformis improves type 2 diabetes mellitus
di: Yuefeng Zhang, et al.
Pubblicazione: (2026)

Real‐world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus
di: Lixin Guo, et al.
Pubblicazione: (2024)

A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus
di: Carol Wysham, et al.
Pubblicazione: (2025)

A study on the utilization of canagliflozin in type 1 diabetes mellitus using real‐world data from four European countries
di: Erica A. Voss, et al.
Pubblicazione: (2025)

Pregnancy and postpartum cardiometabolic outcomes among women with overt diabetes compared to women with normoglycaemia, gestational diabetes and pre‐existing diabetes: A systematic review and meta‐analysis
di: Adarsh Pal, et al.
Pubblicazione: (2025)

Postnatal glycaemic outcomes in women with high‐risk gestational diabetes: Identifying key predictors for early intervention
di: Pei Chia Eng, et al.
Pubblicazione: (2024)

Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes—The Steady Sugar trial
di: Karen Elkind‐Hirsch, et al.
Pubblicazione: (2025)

Risk of diabetic retinopathy and ophthalmic interventions in patients with diabetes mellitus taking different oral anticoagulants
di: Hou‐Ren Tsai, et al.
Pubblicazione: (2025)

Anabolic androgenic steroid use and risk of diabetes mellitus in males
di: Frederik Viggo Lautrup Esmann, et al.
Pubblicazione: (2025)

Synergistic effects of hypertension and diabetes on cardiovascular risk in elderly: Comparative longitudinal analysis of CHARLS and HRS
di: Qiang Su, et al.
Pubblicazione: (2026)

Non‐invasive metabolic biomarkers in initial cognitive impairment in patients with diabetes: A systematic review and meta‐analysis
di: Meng‐Di Chen, et al.
Pubblicazione: (2024)

High‐intensity statin therapy is associated with reduced coronary inflammation on CT in patients with type 2 diabetes mellitus
di: Bryan Wu, et al.
Pubblicazione: (2025)

Empagliflozin for the preservation of beta‐cell function in women with recent gestational diabetes: A randomized placebo‐controlled trial
di: Shamini Murugavel, et al.
Pubblicazione: (2025)

Effects of intensive treatment of Chinese women with gestational diabetes on the risk of offspring being overweight from 3 to 8 years of age
di: Jing Li, et al.
Pubblicazione: (2024)

Retinal vascular density as a potential biomarker of diabetic cerebral small vessel disease
di: Yinqiong Huang, et al.
Pubblicazione: (2024)

Integrated approach of machine learning, Mendelian randomization and experimental validation for biomarker discovery in diabetic nephropathy
di: Yidong Zhu, et al.
Pubblicazione: (2024)

Mediating role of inflammatory biomarkers in the causal effect of body composition on glycaemic traits and type 2 diabetes
di: Liwan Fu, et al.
Pubblicazione: (2024)

Efficacy and safety of chiglitazar add‐on to metformin in type 2 diabetes mellitus ( RECAM study)
di: Leili Gao, et al.
Pubblicazione: (2025)

Spatiotemporal burden, risk factors, and genetic causality of non‐alcoholic fatty liver disease and type 2 diabetes mellitus comorbidity in Europe: A multi‐database analysis
di: Haoyang Hu, et al.
Pubblicazione: (2025)

Enhancing postpartum cardiometabolic health for women with previous gestational diabetes: Next steps and unanswered questions for pharmacological and lifestyle strategies
di: Rajna Golubic, et al.
Pubblicazione: (2024)

Efficacy of high‐intensity interval training in individuals with type 2 diabetes mellitus: An umbrella review of systematic reviews and meta‐analyses
di: Eric Tsz‐Chun Poon, et al.
Pubblicazione: (2025)